The impact of race and ethnicity in breast cancer—disparities and implications for precision oncology

Kelly A. Hirko, Gabrielle Rocque, Erica Reasor, Ammanuel Taye, Alex Daly, Ramsey I. Cutress, Ellen R. Copson, Dae Won Lee, Kyung Hun Lee, Seock Ah Im, Yeon Hee Park

Research output: Contribution to journalArticlepeer-review

Abstract

Breast cancer is the most commonly diagnosed cancer worldwide and is one of the leading causes of cancer death. The incidence, pathological features, and clinical outcomes in breast cancer differ by geographical distribution and across racial and ethnic populations. Importantly, racial and ethnic diversity in breast cancer clinical trials is lacking, with both Blacks and Hispanics underrepresented. In this forum article, breast cancer researchers from across the globe discuss the factors contributing to racial and ethnic breast cancer disparities and highlight specific implications of precision oncology approaches for equitable provision of breast cancer care to improve outcomes and address disparities.

Original languageEnglish
Article number72
JournalBMC Medicine
Volume20
Issue number1
DOIs
StatePublished - Dec 2022

Keywords

  • BRCA mutations
  • Breast cancer
  • CDK4/6 inhibitors
  • Clinical outcomes
  • Disparities
  • Ethnicity
  • PARP inhibitors
  • Precision oncology
  • Race
  • Socioeconomic status
  • Targeted therapy

Fingerprint

Dive into the research topics of 'The impact of race and ethnicity in breast cancer—disparities and implications for precision oncology'. Together they form a unique fingerprint.

Cite this